Physician profile
Michael Alan Morris
NPI 1417119488
$3,550.11
in general payments reported to CMS, 2019-2025
16 companies · $575 in 2025
The $575 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $94.17 · 2021: $617 · 2022: $818 · 2023: $793 · 2024: $514 · 2025: $575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,882.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,882.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,199.19 | 2021-2025 | Clareon, Clareon Panoptix Pro, Ngenuity |
| Abbvie INC. | $591.49 | 2022-2025 | |
| New World Medical,INC. | $523.49 | 2021-2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Clearpath |
| Allergan, INC. | $320.70 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $270.98 | 2022-2024 | Vyzulta, Prolensa, Lotemax Sm |
| Glaukos Corporation | $209.27 | 2020-2024 | Idose |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $155.48 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $75.93 | 2019-2024 | Tecnis Iol, Tecnis Iol |
| Mallinckrodt Hospital Products INC. | $66.97 | 2022-2023 | Acthar |
| Tarsus Pharmaceuticals, INC. | $38.46 | 2025 | Xdemvy |
| Harrow Eye, LLC | $26.60 | 2023 | Iheezo |
| Becton, Dickinson and Company | $24.52 | 2024 | Bard Urinary Drainage Bag |
| Aerie Pharmaceuticals, INC. | $14.12 | 2020 | |
| Shire North American Group INC | $13.68 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.95 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $6.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.